Merrimack Announces Preliminary Data From Pilot Diagnostic Imaging Study of MM-398
April 08, 2014 at 08:01 AM EDT
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced Phase 1 results from a clinical pilot study demonstrating that ...